Stavance (Vancomycin Hydrochloride)

Vancomycin Hydrochloride is a potent antibiotic prescribed for serious bacterial infections including MRSA, endocarditis, and severe pneumonia.

Administered intravenously, typical dosing ranges from 15-20 mg/kg every 8-12 hours, adjusted based on renal function and infection severity.

This medication works by inhibiting bacterial cell wall synthesis, effectively eliminating resistant pathogens.

Common side effects include infusion-related reactions, nephrotoxicity, and ototoxicity, requiring regular monitoring. Stavance delivers reliable efficacy for life-threatening infections when other antibiotics prove ineffective, making it an essential choice for healthcare providers managing complex bacterial complications.